PEPTIDE CORPUS

Tissue Repair & Regeneration

Hexapeptide-9

Space-filling model of Hexapeptide-9

Head-to-head trials against an ingredient that already works are rare among cosmetic peptides, and hexapeptide-9 has one. A randomised, double-blinded trial ran a 0.002 per cent cyclised hexapeptide-9 serum against a 0.002 per cent retinol serum and against vehicle for 56 days, measuring crow's feet and forehead wrinkle number, area and roughness, and the peptide came out ahead of retinol on every measure but one. The peptide itself is a six-amino-acid fragment copied from collagen, applied on the principle that a skin cell reading a collagen fragment will build more collagen. Two things qualify the result: the material tested was a cyclised variant, and the number enrolled was never reported.

Last updated

Studied forWrinkle reduction research · Collagen synthesis research · Skin ageing context
Strongest sourceNovel Cyclized Hexapeptide-9 Outperforms Retinol Against Skin Aging: A Randomized, Double-Blinded, Active- an… (randomised human trial)

Mechanism

A collagen-fragment mimetic that stimulates fibroblast collagen production; cyclisation improves its stability and skin permeability.

Reported effects

What sources associate with this compound. Reported categories, not outcomes we have graded — each would need its own citation and rung.

  • Wrinkle reduction research
  • Collagen synthesis research
  • Skin ageing context

Manufacturer’s claim vendor marketing

For a proprietary cosmetic ingredient the manufacturer is the originator — there is no upstream to defer to, and this is often the only description that exists. It is reproduced as an attributed claim, with the label its source gave it. It is not graded and it is not evidence — the graded studies are under Literature.

Vendor claim (SpecialChem/Ashland datasheet): "Acts as an anti-wrinkle and skin repairing agent. It helps in reducing the length and depth of wrinkles. It enhances epidermal regeneration, protein synthesis and boosts dermal-epidermal junction key proteins." No n= or duration on fetched page.

Manufacturer
Ashland
Sold as
Collaxyl IS

Source page — nofollow, because a vendor link is a reference here, not an endorsement.

Dosing on file unverified

0.002% CHP-9 serum, 1-2x/day (56 days)

Carried from a source that labels it unverified, and reproduced with that label attached. A record of what is reported, not a recommendation. No citation on this page establishes it.

Literature on file 5

Identity

PubChem CID 16129319 computed 3D conformer Space-filling 3D model of Hexapeptide-9, carbon grey, nitrogen blue, oxygen red
Built from the SMILES on this record — the atoms and bonds are exact. The shape is one computed low-energy pose, not a measured structure: a flexible peptide in solution has no single conformation, and where the SMILES leaves a stereocentre undefined the pose commits to one arbitrarily. The skeletal formula below claims connectivity and nothing more, which is what we actually know.
Skeletal formulathe canonical depiction
2D chemical structure of Hexapeptide-9

Drawn by PubChem from CID 16129319, the identifier on this record.

Molecular weight
582.6
Molecular formula
C24H38N8O9
CAS number
885024-94-2
PubChem CID
16129319
InChI key
OGNHOGPWQTWKGQ-VGWMRTNUSA-N
SMILES
C1C[C@H](N(C1)C(=O)CN)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)O
InChI
InChI=1S/C24H38N8O9/c25-11-19(35)31-9-1-3-15(31)22(38)29-13(5-7-17(26)33)21(37)28-12-20(36)32-10-2-4-16(32)23(39)30-14(24(40)41)6-8-18(27)34/h13-16H,1-12,25H2,(H2,26,33)(H2,27,34)(H,28,37)(H,29,38)(H,30,39)(H,40,41)/t13-,14-,15-,16-/m0/s1

Also called

  • Collaxyl IS
  • Hexapeptide-9

Notes unverified prose

2025 RCT: cyclized Hexapeptide-9 (CHP-9) outperformed retinol for skin aging at 56 days; 28-day study: improved elasticity & firmness; RCT: cyclized hexapeptide-9 (CHP-9) outperformed retinol

Not on file 2

1 of the 8 fields we track hold nothing on this record, and each says why. 1 further absence is named below. A blank field is a bug; a named absence is a finding.

Each field links to every other record missing the same thing. The full ledger holds 765 gaps across 163 records.

Share this record

Share card for Hexapeptide-9: structure, evidence rung and sources on file
www.peptidecorpus.com/peptides/hexapeptide-9